Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
Neutrophils disguise tumors by synthesizing and secreting arginase
From the Houghton lab and collaborating Randolph lab, Clinical Research and Public Health Sciences Divisions
Immune signature reveals new therapeutic potential in colon cancer
From Dr. Jeroen Huyghe and the Peters Lab, Public Health Sciences Division
Award will fund research into new metastatic prostate cancer therapies
Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Fred Hutchinson Cancer Center receives $710.5 million gift to accelerate cancer and infectious disease research
The landmark gift from the Bezos family will fund multiple scientific priorities, including clinical trials support, new translational research capabilities and recruitment
Machine learning identifies biomarkers that predict a patient’s response to immunotherapy
From the Gujral Lab, Human Biology Division
Making immunotherapy more effective against small cell lung cancer
Human trial opens after experimental drug improves tumor growth suppression in mice
Hutch scientists receive $25M to solve breast cancer metastasis
New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread
How does leukemia escape from immunotherapy?
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements
Vaccination after CAR-T-cell therapy
From the Hill group, Vaccine and Infectious Disease Division and the UW/Fred Hutch Cancer Consortium
What’s new in breast cancer research? San Antonio conference goes hybrid for 2021
Hutch researchers look at overdiagnosis, cardiotoxicity of chemotherapy, cost of a new surveillance method and more
Investment in business development pays dividends for research, patients
Fred Hutch tech transfer specialists help scientists navigate path to bringing innovations to patients
New computational method opens window into immune cell behavior
Approach links T-cell receptor genes to T-cell activity and function at single-cell resolution
Tip Sheet: Disparities in cancer outcomes, catching up on cancer screenings, boosting immunotherapy effectiveness and SARS-CoV-2 origins
Summaries of recent Fred Hutch research findings and other news
5 reasons why a cancer research center has virology expertise
Pathogens can cause diseases, the immune system can fight them
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
What’s new in breast cancer research? SABCS20 goes virtual
Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Summaries of recent Fred Hutch research findings and other news, plus resources for the American Society of Hematology’s annual meeting